M. Al-Dughaishi, A. Shalaby, K. Al-Ribkhi, A. Boudaka, M.-R. Boulassel, and J. Saleh, “The Value of Programmed Death Ligand 1 Expression in Cancer Patients Treated with Neoadjuvant Chemotherapy”, Sultan Qaboos Univ Med J, vol. 19, no. 4, pp. e277–283, Dec. 2019.